BIOCRYST PHARMACEUTICALS INC — All Filings
1,001 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13E3/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000742 | Mar 26, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000882796-26-000017 | Mar 24, 2026 | Mar 20, 2026 |
| 144 | — | 0001959173-26-002529 | Mar 20, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000882796-26-000015 | Mar 18, 2026 | Mar 16, 2026 |
| 144 | — | 0001959173-26-002383 | Mar 16, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000882796-26-000013 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | PRIMARY DOCUMENT | 0000882796-26-000011 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | PRIMARY DOCUMENT | 0000882796-26-000009 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | PRIMARY DOCUMENT | 0000882796-26-000007 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | PRIMARY DOCUMENT | 0000882796-26-000005 | Mar 3, 2026 | Feb 27, 2026 |
| 144 | — | 0001959173-26-001679 | Mar 2, 2026 | — |
| 10-K | 10-K | 0001628280-26-012240 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001171843-26-001119 | Feb 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001193805-26-000127 | Feb 12, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000882796-26-000003 | Jan 27, 2026 | Jan 23, 2026 |
| 3 | — | 0001171843-26-000446 | Jan 27, 2026 | Jan 23, 2026 |
| 8-K/A | FORM 8-K/A | 0001171843-26-000405 | Jan 23, 2026 | Oct 14, 2025 |
| 8-K | 8-K | 0001140361-26-002200 | Jan 23, 2026 | — |
| 8-K | FORM 8-K | 0001171843-26-000213 | Jan 12, 2026 | — |
| 3 | — | 0001171843-26-000173 | Jan 9, 2026 | Jan 1, 2026 |
| 8-K | FORM 8-K | 0001171843-26-000154 | Jan 9, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000045 | Dec 23, 2025 | Dec 19, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000043 | Dec 23, 2025 | Dec 19, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000041 | Dec 23, 2025 | Dec 19, 2025 |
| 144 | — | 0001959173-25-007875 | Dec 22, 2025 | — |
| 4 | — | 0001171843-25-008039 | Dec 19, 2025 | Dec 18, 2025 |
| 4 | — | 0001171843-25-008038 | Dec 19, 2025 | Dec 17, 2025 |
| 4 | — | 0001171843-25-008037 | Dec 19, 2025 | Dec 17, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000038 | Dec 19, 2025 | Dec 17, 2025 |
| EFFECT | — | 9999999995-25-003840 | Dec 18, 2025 | — |
| 424B3 | 424B3 | 0001140361-25-046040 | Dec 18, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000036 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000033 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000031 | Dec 16, 2025 | Dec 12, 2025 |
| 144 | — | 0001959173-25-007729 | Dec 15, 2025 | — |
| S-4/A | S-4/A | 0001140361-25-045461 | Dec 15, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-007909 | Dec 12, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-007878 | Dec 11, 2025 | Dec 9, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000027 | Dec 3, 2025 | Dec 1, 2025 |
| 144 | — | 0001959173-25-007471 | Dec 3, 2025 | — |
| 425 | 425 | 0001140361-25-044111 | Dec 3, 2025 | — |
| 8-K | 8-K | 0001140361-25-044110 | Dec 3, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000023 | Dec 2, 2025 | Nov 28, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000021 | Dec 2, 2025 | Nov 28, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000019 | Dec 2, 2025 | Nov 28, 2025 |
| 144 | — | 0001959173-25-007427 | Dec 2, 2025 | — |
| 144 | — | 0001959173-25-007391 | Dec 1, 2025 | — |
| 144 | — | 0001628280-25-054000 | Nov 25, 2025 | — |
| 144 | — | 0001628280-25-053613 | Nov 21, 2025 | — |
| S-4 | S-4 | 0001140361-25-042879 | Nov 20, 2025 | — |